MyCelx Technologies Corporation Contract Secured for PFAS Remediation System
January 24 2023 - 2:00AM
RNS Non-Regulatory
TIDMMYX
MyCelx Technologies Corporation
24 January 2023
24 January 2023
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Rental Contract Secured for PFAS Remediation System at
Landfill
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water and clean air technology company, is pleased to
announce that it has secured a paid 6-month trial for treatment of
PFAS in the United States. PFAS, which stands for per-fluoroalkyl
and poly-fluoroalkyl compounds, are a collection of long-lasting
manmade toxic chemicals which present a global threat to human
health and the environment.
MYCELX has secured a contract for its fully containerized,
mobile PFAS remediation system which includes MYCELX infused
cartridge filtration and Performer(TM) media. The system will be
utilized for treating PFAS contaminated leachate from a solid waste
landfill. The rental is expected to successfully demonstrate the
ability of the proprietary MYCELX technology to completely remove
all identified PFAS chemicals to non-detectable concentrations in a
single pass.
The revenue from this trial is not anticipated to alter
management's revenue expectations for the year.
Connie Mixon, CEO, commented:
"We are pleased to announce this promising paid trial. The award
is further proof of the strong momentum we are generating as a
business in the PFAS solutions market, building on the Company's
success with its previous trial in America and installations in
Australia with an important distributor. In addition, in scenarios
of solid waste landfill, we continue to see a growing demand for
technologies that are able to treat the co-contaminants that are
present with PFAS.
As a Group, we are firmly focused on achieving greater market
share in three core areas; the Middle East, PFAS and REGEN. All of
which we believe will be key growth drivers for MYCELX in 2023. We
look forward to updating all our stakeholders on further corporate
developments over the coming months."
For further information, please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity Limited (Nomad and Sole Broker)
Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000
Gordon Hamilton
Celicourt Communications (Financial PR)
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRANKNBKCBKDQDB
(END) Dow Jones Newswires
January 24, 2023 02:00 ET (07:00 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024